Arsenite-loaded albumin nanoparticles for targeted synergistic chemo-photothermal therapy of HCC

Arsenic trioxide (ATO, As 2 O 3 ), an active ingredient of traditional Chinese medicine, has been approved by the U.S. Food and Drug Administration as an effective therapeutic agent for acute promyelocytic leukemia (APL).